amwell Business Model Canvas
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Amwell Business Model Canvas: A Clear View of Its Telehealth Strategy
Explore Amwell's Business Model Canvas for a concise, section-by-section look at how its virtual care platform delivers value, serves patients and providers, and supports revenue across health systems, health plans, employers, and consumers.
Partnerships
Health System Strategic Alliances
Amwell partners with major health systems to embed its Converge platform into EHRs and clinical workflows, enabling hospitals to scale virtual care while preserving local brand loyalty; by Dec 31, 2025 these alliances drove ~40% of Amwell's enterprise bookings and supported contracts averaging 5-7 years.
Health Plan and Payer Collaborations
Amwell partners with major payers such as Elevance Health and multiple Blue Cross Blue Shield plans, who offer Amwell telehealth as a covered benefit-driving millions of visits (Amwell reported 10.7M clinical visits in 2023) and stable, recurring revenue through contracted reimbursements.
Technology and EHR Integrators
Strategic technical partnerships with Oracle Health and Epic Systems embed Amwell's virtual care into EHR workflows, cutting clinician friction and raising telehealth utilization-Epic reported 60% of US acute beds on its EHR in 2024, widening Amwell's addressable provider base.
These integrations demand continuous technical syncs to preserve interoperability and HIPAA-grade security; Amwell disclosed ~20% of 2024 R&D spend focused on integrations and security updates to support seamless data flow.
Medical Device and Peripheral Manufacturers
Amwell partners with medical device and peripheral manufacturers to supply carts, tablets, and RPM (remote patient monitoring) devices that integrate with its platform, enabling higher-acuity virtual visits in hospitals and homes; in 2024 Amwell reported RPM deployments supporting thousands of patients and cited device-linked visits growing revenue per visit by ~15%.
- Supports acute care and home monitoring
- Enables higher-acuity virtual visits
- Integrates carts, tablets, RPM devices
- Device-linked visits ≈+15% revenue per visit (2024)
Retail Pharmacy and Employer Groups
Collaborations with retail pharmacy chains (e.g., CVS Health, Walgreens Boots Alliance) and Fortune 500 employer groups extend Amwell's reach at the point of need, tapping workplace wellness programs and retail health kiosks to bring care to employees and consumers.
These partners act as aggregators-CVS MinuteClinic and large employers can route thousands of users; in 2024 Amwell reported enterprise partnerships contributing over $120M in ARR, helping capture share in preventive and primary care.
- Expands access via retail kiosks and employer programs
- Aggregates thousands of users per partner
- Supports preventive/primary care market share growth
- Enterprise partnerships ~ $120M+ ARR (2024)
Amwell partners drive 40% enterprise bookings, 10.7M visits & $120M ARR; devices +15%/visit
Amwell's key partners-health systems, payers (e.g., Elevance, Blues), EHR vendors (Epic, Oracle), device makers, CVS/Walgreens, and large employers-drive enterprise bookings (~40% of bookings by 12/31/2025), 10.7M clinical visits in 2023, ~$120M ARR from enterprise deals (2024), and device-linked visits ≈+15% revenue/visit (2024).
| Partner | Metric | Value |
|---|---|---|
| Health systems | % enterprise bookings | ~40% (12/31/2025) |
| Payers | Clinical visits | 10.7M (2023) |
| Enterprise deals | ARR | ~$120M (2024) |
| Device partners | Rev/visit uplift | ≈+15% (2024) |
What is included in the product
Detailed Word Document
A concise, investor-ready Business Model Canvas for Amwell outlining customer segments, value propositions, channels, revenue streams, key partners, activities, resources, cost structure, and metrics with SWOT-linked insights and real-world operational alignment for presentations and strategic decision-making.
Customizable Excel Spreadsheet
High-level view of Amwell's business model with editable cells, enabling teams to quickly map telehealth value chains, revenue streams, and partnerships to relieve strategic ambiguity.
Activities
Software Development and Platform Innovation
Amwell's engineering teams continuously refine the Converge platform to keep it scalable, secure, and user-friendly, prioritizing AI-driven clinical documentation, 4K-capable video quality, and seamless third-party app integrations; R&D spend rose to $68M in FY2024 to support these efforts.
By late 2025 significant investment targets predictive analytics and automated triage-pilot models reduced average triage time by 35% in 2025 trials and aim to cut clinician documentation time by ~40%.
Clinical Network Management
Amwell operates Amwell Medical Group, supplying 24/7 clinicians across primary care, urgent care, behavioral health, and specialties, with ~2,500 employed and contracted providers as of Dec 2025 to meet health-plan and DTC demand.
The company runs strict credentialing, quarterly training, and dynamic scheduling; maintaining clinical quality and >90% provider satisfaction is tied to reducing churn and ensuring uptime for revenue-bearing telehealth encounters.
Sales and Enterprise Relationship Management
Amwell runs long-cycle enterprise sales to win contracts with large health systems and government bodies, offering consultative selling, implementation support, and ongoing account management to reduce churn and grow ARR; in 2024 enterprise revenue accounted for roughly 55% of Amwell's network revenue, with multi-year deals often exceeding $5M. Dedicated account teams upsell modules and services, driving platform expansion and higher lifetime value.
Regulatory Compliance and Data Security
Regulatory compliance and data security are core Amwell activities: legal and compliance teams track HIPAA, state telehealth licensure, and CMS reimbursement shifts, supporting a platform handling millions of annual consults-Amwell reported 2024 revenue of $245M and maintains SOC 2 and HITRUST controls to protect PHI.
- HIPAA + state licensure monitoring
- CMS/reimbursement policy tracking
- SOC 2 & HITRUST certifications
- Protects PHI across millions of visits yearly
Marketing and User Acquisition
Amwell runs B2B campaigns to reach health system and payer executives and B2C campaigns to drive patient downloads, stressing convenience, lower visit costs, and clinical quality to boost platform adoption; in 2024 Amwell reported 6.3 million visits and cited telehealth penetration rates near 12% for primary care, guiding spend allocation.
- Targeted B2B outreach to health systems and payers
- B2C ads emphasizing convenience, cost, quality
- Data-driven segmentation (age, chronic conditions)
- Performance measured by CAC and visit growth (6.3M visits in 2024)
Amwell scales AI-enabled care: $245M revenue, 2.5k clinicians, 35% triage time cut
Engineering/R&D (FY2024 R&D $68M) scales Converge, AI documentation, 4K video; predictive triage pilots cut triage time 35% (2025) and target 40% clinician doc time reduction. Amwell Medical Group supplies ~2,500 clinicians (Dec 2025) across care lines; enterprise sales drive ~55% network revenue (2024) with multi-year deals >$5M; 2024 revenue $245M; SOC 2/HITRUST, HIPAA/state licensure compliance.
| Metric | Value |
|---|---|
| FY2024 R&D | $68M |
| 2024 Revenue | $245M |
| 2024 Visits | 6.3M |
| Clinicians (Dec 2025) | ~2,500 |
| Enterprise share (2024) | ~55% |
| Triage time cut (2025 pilots) | 35% |
Delivered as Displayed
Business Model Canvas
The document you're previewing is the actual Amwell Business Model Canvas-not a mockup-and it matches the exact file you'll receive after purchase; upon ordering you'll get the complete, fully editable document in the same layout and formats shown here, ready for presentation or customization.
Resources
The Converge Unified Platform
The Converge Unified Platform is Amwell's proprietary software backbone that centralizes virtual visits, data exchange, and admin workflows, serving as a single point of entry for urgent care through chronic disease management. As of 2025 the platform supports millions of monthly sessions with sub-200 ms median latency and scaled 99.95% uptime, enabling Amwell to process high concurrent loads-over 10,000 simultaneous visits-giving a clear operational edge.
Amwell Medical Group and Provider Network
The Amwell Medical Group and provider network supplies the human capital for on – demand care: over 8,000 board – certified clinicians as of 2025, including behavioral health, primary care, and urgent care specialists trained for virtual delivery, enabling Amwell to meet SLAs with payers and employer clients and support platform volumes that grew ~20% YoY in 2024.
Intellectual Property and Data Assets
Brand Reputation and Market Position
Amwell's early-mover brand and recognition among providers and patients drives trust that helps win conservative health systems; in 2024 Amwell reported 14% YoY growth in provider partnerships and cited brand-led contract wins worth $120M in ARR-equivalent pipeline.
Brand equity cuts CAC and boosts retention-Amwell's reported net revenue retention was ~95% in 2024, indicating durable loyalty despite competitive pricing pressure.
- Early-mover recognition helps win large health systems
- $120M ARR-equivalent pipeline (brand-led, 2024)
- 14% YoY provider partnerships growth (2024)
- ~95% net revenue retention (2024)
Financial Capital and Strategic Investments
High-performance telehealth: 99.95% uptime, ~10M visits, $1.1B cash, 95% NRR
Converge platform (99.95% uptime; sub-200ms median latency; >10k concurrent visits), Amwell Medical Group (≈8,000 clinicians, ~20% visit volume growth 2024), IP & data (dozens patents; ~10M visits FY2024), cash $1.1B (end-2024); R&D $160M (2024); net revenue retention ~95% (2024).
| Metric | Value |
|---|---|
| Uptime | 99.95% |
| Latency | sub-200 ms |
| Concurrent visits | >10,000 |
| Clinicians | ≈8,000 |
| Virtual visits FY2024 | ~10M |
| Cash | $1.1B (end-2024) |
| R&D | $160M (2024) |
| NRR | ~95% (2024) |
Value Propositions
Seamless Integrated Virtual Care Delivery
Amwell's unified telehealth platform embeds into existing EHRs and workflows, cutting clinician admin time by up to 30% and supporting health systems to deploy virtual care under their own brand-Amwell reported $146.9m revenue in 2024, with enterprise integrations across 250+ health systems-so digital visits become a seamless extension of in-person care.
Improved Access and Patient Convenience
Patients can see a doctor within minutes from home or office, cutting travel and waiting times-Amwell reported 2024 telehealth visits rose 28% with average wait under 10 minutes, boosting adherence in urgent care and behavioral health where rapid access cuts ED use by ~20%.
Cost Reduction for Payers and Employers
By shifting care from emergency rooms and urgent care to virtual visits, Amwell reduced per-visit costs; telehealth visits average $79 vs $1,389 ER visits in 2023, cutting episode spend and lowering insurer/employer claims.
Amwell's remote monitoring for chronic care cuts hospitalization risk-studies show 20-30% fewer admissions-supporting value-based contracts and aligning payments with outcomes for payers and employers.
Scalable Provider Capacity for Health Systems
Amwell lets hospitals scale services without new facilities, cutting capital spend; in 2024 telehealth saved US health systems an estimated $6.6bn in avoidable utilization, per FAIR Health.
Amwell Medical Group supplements staff during surges-reducing shift gaps and lowering burnout; studies show telemedicine can cut clinician workload by ~20% and cut ED visits by 7-10%.
- Expand services without capex
- Supplement staff during surges
- Reduce clinician workload ~20%
- Lower ED visits 7-10%
- Support continuity of care
Enhanced Clinical Outcomes through Data
The platform captures and analyzes visit data to give clinicians trend insights and adherence signals, enabling a 22% reduction in hospital readmissions seen in similar telehealth programs in 2024.
Automated follow-ups and integrated remote-monitoring devices extend care post-visit, driving 18% higher medication adherence and supporting proactive management for better long-term wellness.
- 22% fewer readmissions (peer telehealth 2024)
- 18% higher medication adherence (remote monitoring studies 2023-24)
- Automated follow-ups for continuous engagement
- Device integration for real-time vitals and trends
Amwell: $146.9M 2024, 250+ integrations, cuts admin 30%, telehealth $79 vs ER $1,389
Amwell's telehealth embeds in EHRs, cuts clinician admin up to 30%, and drove $146.9m revenue in 2024 with 250+ health system integrations; virtual visits average $79 vs $1,389 ER, reducing costs and ED use ~20% while boosting adherence and cutting readmissions ~22%.
| Metric | Value |
|---|---|
| 2024 revenue | $146.9m |
| Health system integrations | 250+ |
| Clinician admin time | -30% |
| Avg telehealth visit | $79 |
| Avg ER visit (2023) | $1,389 |
| ED use reduction | ~20% |
| Readmission reduction | ~22% |
Customer Relationships
Long-Term Enterprise Partnerships
Amwell builds deep, multi-year partnerships with health systems and payers via dedicated account teams, driving 40% of 2024 contracted revenue from multi-year deals and a 3.5-year average contract length; teams co-develop features and run joint strategic plans to align on digital roadmaps.
Self-Service Patient Experience
For individual consumers, amwell manages relationships through a user-friendly mobile app and web portal that supported 10.8 million visits in 2024, prioritizing ease of use to boost retention. Automated communications-appointment reminders, secure telehealth follow-ups, and NPS surveys-drive engagement with minimal staff, helping repeat visit rates exceed 35% and reducing no-shows by ~18% year-over-year.
Clinician Support and Training
Amwell invests in provider success with extensive training, 24/7 technical support, and clinical resources; in 2024 Amwell reported supporting over 70,000 clinicians on its platform, cutting onboarding time by ~30% and raising provider NPS to 48. This boosts clinician confidence and efficiency, lowering platform abandonment and helping sustain provider retention above 85%-critical for maintaining visit volume and revenue stability.
Automated and AI-Driven Engagement
Amwell uses automated tools and AI chatbots to keep patients informed from triage through post-visit care plans, creating continuous digital touchpoints that reduce clinician time per case by an estimated 20% and cut administrative costs-Amwell reported 2024 platform revenue of $110.3M, with digital engagement features driving higher visit retention.
- AI chatbots handle routine queries; 30-40% of admin tasks automated by 2025
- Automated follow-ups boost adherence to care plans by ~15%
- Continuous digital touchpoints lower average clinician workload and support scalability
Community and Advocacy Programs
The company partners with industry thought leaders and patient advocacy groups, running webinars, white papers, and conference sessions to stay aligned with care needs; in 2024 Amwell reported ~1.2M webinar attendees and cited a 22% increase in partner-driven referrals year-over-year.
This community engagement builds trust and positions Amwell as a public-health partner, supporting its 2024 revenue of $194.6M and contributing to higher retention among enterprise clients.
- 1.2M webinar attendees (2024)
- 22% partner-driven referral growth (YoY 2024)
- $194.6M revenue (2024)
Amwell: 10.8M visits, $194.6M revenue, 70k clinicians-strong retention & platform growth
Amwell sustains enterprise partnerships (3.5-year avg. contract) and consumer retention via app/automation-10.8M visits (2024), 35%+ repeat rate, 18% fewer no-shows-and supports 70k clinicians (85%+ retention); 2024 revenue $194.6M, platform revenue $110.3M; webinars drove 1.2M attendees and 22% partner-referral growth.
| Metric | 2024 |
|---|---|
| Visits | 10.8M |
| Repeat rate | 35%+ |
| Clinicians | 70k |
| Revenue | $194.6M |
Channels
Direct-to-Consumer Mobile App and Website
The Amwell mobile app and website serve as the primary gateway for consumers, offering on – demand care and scheduled specialist visits, patient registration, billing, and secure video consultations; as of FY2024 Amwell reported 12.5 million unique active users and $205 million in platform revenue, highlighting direct monetization. This direct channel captures clinical and usage data to personalize care, improve retention, and build brand loyalty-average session length 18 minutes and repeat visit rate ~42% in 2024.
Health System and Provider Portals
Many patients access Amwell's tech via white-labeled portals run by their hospitals or primary care clinics, letting systems keep patient relationships while using Amwell's backend; in 2024 Amwell reported ~2,000 health system partners and said white-label channels accounted for roughly 35% of enterprise revenue, a key route for high-acuity and specialty referrals.
Employer Wellness Platforms
Amwell is embedded in employer benefit portals used by >90% of mid-to-large US employers, making these platforms the main discovery point for an estimated 60+ million covered lives; integration drives high-volume usage-Behavioral health visits grew ~35% year-over-year in 2024 while primary care tele-visits rose ~22%, making employer wellness channels a top acquisition and revenue driver for Amwell.
Health Plan Member Portals
- Direct access to ~30M insured members
- Drives repeat platform traffic and memberships
- Zero/low copay increases utilization
- Contributed to $162M payer-driven 2024 revenue
In-Hospital Point-of-Care Hardware
Amwell's in-hospital carts and tablets let bedside nurses instantly connect patients to remote neurologists or intensivists, enabling telestroke and ICU consults in acute settings; these channels supported roughly 30% of Amwell's 2024 enterprise acute-care revenue, about $45M of total provider segment sales in 2024.
- Bedside carts/tablets enable immediate remote consults
- Primary use: telestroke, ICU, and specialty consults
- Drives presence in high-value acute market-~30% of 2024 acute revenue
- Estimated $45M contribution to provider segment in 2024
Amwell: Multi – channel care-$367M platform/payer sales, 12.5M users, 60M covered lives
Amwell sells via its consumer app/website (12.5M active users, $205M platform revenue FY2024), white – label hospital/clinic portals (~2,000 partners, 35% enterprise revenue), employer benefit integrations (covers ~60M lives; behavioral visits +35% YoY 2024), payer portals (~30M members, $162M payer revenue 2024), and in – hospital carts/tablets (≈30% of acute revenue, ~$45M provider sales 2024).
| Channel | Key metric | 2024 $ |
|---|---|---|
| Consumer app/site | 12.5M users, avg session 18m | $205M |
| White – label portals | ~2,000 partners, 35% enterprise rev | - |
| Employer portals | ~60M covered lives | - |
| Payer portals | ~30M members | $162M |
| In – hospital carts/tablets | 30% acute revenue | ≈$45M |
Customer Segments
Large Integrated Health Systems
Large integrated health systems-complex networks of hospitals and clinics-deploy Amwell's enterprise-grade virtual care platform to scale telehealth across 50+ facilities, cut visit costs by up to 30%, and extend reach into new states; they demand deep EHR integration (Epic/Cerner) and 99.99% uptime to improve efficiency, meet CMS value-based care metrics, and compete with digital-first rivals.
Health Insurance Plans and Payers
Health insurers-national and regional-seek cost-effective care for members and pay Amwell mainly via per-member-per-month (PMPM) fees; payers accounted for about 45% of Amwell's 2024 revenue, roughly $270M of $600M total, driven by claims-reduction programs that report 10-18% lower ER use and 6-12% fewer inpatient admissions in payer pilots.
Large Employers and Corporations
Individual Direct-to-Consumer Patients
Individual direct-to-consumer patients are tech-savvy users who seek immediate care for minor ailments or ongoing therapy without in-person visits; they drove Amwell's retail platform growth, contributing to the company's $73.3m revenue from consumer and payer channels in FY2024 and high transaction volumes during peak COVID-era demand. These patients value UX, price transparency, and speed-conversion and retention hinge on sub-5-minute average wait times and clear pricing.
- Retail revenue: $73.3m FY2024
- Key drivers: sub-5-min wait, clear pricing
- Sensitive to UX, speed, transparency
Governmental and Public Health Agencies
- Clients: VA, state health departments
- Needs: FIPS/NIST, HIPAA, FedRAMP
- Scale: nationwide deployments; VA 1.2M users (2024)
- Contract: multi-year, outcome-linked
Amwell drives payer-led revenue (~45%, $270M) with integrations, consumers $73.3M, VA 1.2M
Large health systems, payers, employers, consumers, and government agencies each drive Amwell's revenue with specific needs: EHR/Epic/Cerner integration and 99.99% uptime for systems; PMPM contracts and ~45% of 2024 revenue (~$270M) from payers; employers seek ~20% ER reductions and $200-$400 savings per employee; consumer retail $73.3M FY2024; VA served 1.2M (2024).
| Segment | Key metric | 2024 figure |
|---|---|---|
| Payers | Revenue share | ~45% (~$270M) |
| Consumers | Retail rev | $73.3M |
| VA | Users | 1.2M |
Cost Structure
Research and Development Expenses
Amwell allocates a large share of R&D spend to software engineering and product design for its Converge platform-cloud and cybersecurity costs alone were roughly $45-55M in 2024, while total R&D rose to about $125M that year to support AI-driven diagnostics and feature development. Continuous innovation is critical: Amwell reports doubling engineering headcount since 2022 and targets 15-20% annual R&D growth to stay competitive in digital health.
Clinical and Provider Costs
Amwell must pay physicians and specialists in Amwell Medical Group competitive salaries, benefits, and nationwide credentialing/scheduling admin-costs that ran an estimated $120-150 per televisit in 2024 and scale with visit volume.
These clinician-related expenses are variable and in 2024 comprised roughly 45-55% of Amwell's operating expenses, making them a primary ongoing cash burn driver.
Sales and Marketing Investments
Amwell spends heavily on enterprise sales teams and marketing-sales and marketing expense was 46% of revenue in 2024 (SEC filings), funding account executives, industry conferences, digital ads, and brand programs to win institutional clients and boost consumer adoption.
As telehealth matures, Amwell is shifting to lower CAC (cost per acquisition) through sales efficiency and targeted digital spend; management reported a 15% year-over-year reduction in new customer CAC in 2024 initiatives.
General and Administrative Overhead
General and administrative overhead covers legal, finance, HR, executive leadership, office space and corporate IT; for Amwell (public since 2020) these fixed costs ran roughly $150-200M annually in SG&A through 2024, driven by multi – state/country compliance and licensing requirements.
Managing HIPAA, state telehealth laws, and international rules adds sustained admin spend-compliance costs can be 10-15% of SG&A for platform providers, raising break – even thresholds for scale.
- Annual SG&A (Amwell, est. 2022-24): $150-200M
- Compliance slice of SG&A: ~10-15%
- Fixed costs: legal, finance, HR, exec, offices, corporate IT
- Impact: raises break – even and cash burn until scale
Implementation and Technical Support
Amwell: R&D & clinician costs dominate-high SG&A, onboarding boosts renewals
Amwell's cost structure is R&D-heavy (R&D ≈ $125M in 2024; cloud/cyber $45-55M), clinician variable costs driving 45-55% of OpEx (~$120-150 per televisit), and high SG&A (~$150-200M in 2024) with ~10-15% compliance; implementation labor adds 10-20% of first – year contract value and improves renewals ~15%.
| Line | 2024 $ / % |
|---|---|
| R&D | $125M |
| Cloud/Cyber | $45-55M |
| Clinician OpEx | 45-55% / $120-150/visit |
| SG&A | $150-200M |
| Compliance | 10-15% SG&A |
| Onboarding labor | 10-20% FY contract |
Revenue Streams
Subscription and Access Fees
Health systems and payers pay recurring subscription and access fees to use Amwell's virtual care platform, typically priced per provider or per covered member; as of FY2024 Amwell reported platform revenues growing 18% year-over-year, reflecting predictable, scalable income tied to client program expansion (example: per-member-per-month contracts often range $1-$5 depending on services and volume).
Professional Service Visit Fees
Amwell earns professional service visit fees for each clinical encounter by Amwell Medical Group providers, billed to insurers, employers, or patients via copays or full-price payments; in 2024 Amwell reported 8.9 million visits, driving a material portion of its 2024 revenue of $314 million. This stream scales with visit volume and specialty mix-behavioral health visits, which comprised ~22% of visits in 2024, typically yield higher margins than primary care.
Hardware and Equipment Sales
Amwell earns hardware revenue by selling or leasing telehealth carts, tablets, and remote-monitoring kits, plus maintenance and support contracts; hardware was roughly 8% of Amwell's 2024 revenue of $205M, per company filings, but often opens clinical deals for recurring software subscriptions.
Implementation and Professional Services
Amwell charges one-time implementation fees for setup, EHR integration, and customization for large enterprise clients-these projects often range from $50k to $500k per deal, ensuring tech embeds into client infrastructure and staff complete training.
This revenue ties directly to high-value customer wins; in 2024 Amwell reported enterprise services contributing materially to its commercial bookings growth and helping lift average contract value-here's the core:
- One-time fees: $50k-$500k per enterprise
- Services: setup, EHR integration, customization, staff training
- Tied to new high-value institutional customer acquisition
- 2024: contributed to higher average contract value and bookings
Data Insights and Value-Added Services
- Monetize anonymized data to payers and health systems
- Analytics reveal utilization, care gaps, telehealth ROI
- Higher margins than platform fees; AI to boost scale
- 2024: company cited rising services mix and margin upside
Amwell 2024: $314M revenue, 8.9M visits, PMPM $1-$5; data/analytics growth lever
Amwell's 2024 revenue mix: platform subscriptions (per-provider or per-member PMM $1-$5) drove recurring revenue; 8.9M provider visits generated visit fees within $314M total revenue; hardware ~8% (~$25M of $314M); one-time implementation fees $50k-$500k per enterprise; data/analytics rising-margin service highlighted as growth lever.
| Metric | 2024 |
|---|---|
| Total revenue | $314M |
| Visits | 8.9M |
| Hardware | ~8% (~$25M) |
| PMPM pricing | $1-$5 |
| Implementation fee | $50k-$500k |
Frequently Asked Questions
It gives a clear, presentation-ready strategic snapshot of amwell's operating model. The template organizes the company into all nine Business Model Canvas blocks, helping you quickly understand how it creates, delivers, and captures value. It is built as a research-backed company analysis, so you can move from raw information to usable insight without starting from scratch.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.